Practitioner Diversion Awareness Conference - June 14, 2019; Grand Rapids, Michigan
June 14, 2019; Grand Valley State University – Grand Rapids, Michigan
The Drug Enforcement Administration (DEA) Detroit Field Division hosted the Michigan Practitioner Diversion Awareness Training at Grand Valley State University's Pew Campus on June 14, 2019 in Grand Rapids, Michigan. The conference was developed and designed to address issues of the diversion and abuse of pharmaceutical controlled substances.
Nearly 600 practitioners registered for the conference, to include physicians, nurse practitioners, physician assistants, dentists, and other DEA registrants. Practitioners attended the event either in person or via livestream. Conference attendees received nearly seven hours of information on a variety of topics. The presentations, given by DEA, state, and private instructors, included: DEA's Diversion Control mission; Michigan Automated Prescription System and state legislative/enforcement updates; the effect of surgery on opioid prescriptions; the physiology of addiction; health care fraud; methods of diversion and drug trends; electronic prescribing; and Medication-Assisted Treatment.
Selected presentations from the Grand Rapids, Michigan PDAC are below.
DEA Diversion Control Mission and Overview – Kathy Federico, Diversion Program Manager, DEA Detroit
The Surgeon's Role in the Opioid Epidemic – Michael Englesbe, MD
Michigan Automated Prescription System and State Legislative Updates – Amber Daniels, MAPS Analyst, Michigan Department of Licensing and Regulatory Affairs
LARA Licensee Complaint and Enforcement – Andrew Hudson, Section Manager, Pharmacy and Drug Monitoring, Michigan Department of Licensing and Regulatory Affairs
Addiction Physiology – Ismael David Yanga III, MD
Pharmaceutical Diversion in Medicare – Christopher Gould
Methods of Diversion and Drug Trends – Kathy Federico, Diversion Program Manager, and William Chamulak, Supervisory Special Agent, DEA Detroit
Electronic Prescribing of Controlled Substances and PDMP Integration – Carl Christensen, MD
Recognizing & Treating Opioid Dependence in your Clinic – Abdulhassan Saad, MD
DEA Initiatives and Next Steps – Kathy Federico, Diversion Program Manager, DEA Detroit